Special cereal-sourced special dietary food for patients with knee osteoarthritis

By preparing a complex special food for grains such as millet, barley, buckwheat, quinoa, oats and sorghum, combined with the site of action of SPOCK2 protein, the nutritional needs of patients with knee osteoarthritis are solved, and the prevention and treatment of knees are achieved The effect of osteoarthritis of joints and has the advantages of industrial production and safety.

CN119014512APending Publication Date: 2024-11-26XIAN HONGHUI HOSPITAL
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410628814.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-05-21
Publication Date
2024-11-26

AI Technical Summary

Technical Problem

The existing market lacks special foods from cereals for patients with osteoarthritis of knee joints, and cannot effectively meet their special physiological state and nutritional needs.

Method used

A complex special food was prepared by using millet, barley, buckwheat, quinoa, oats and sorghum, and by detecting the binding sites of the co-expressed small molecules with SPOCK2 protein, and made into 100 -120 mesh fine grain-source special food, determine the optimal ratio is 1:1:1:1:1:1, which is suitable for dietary intervention in patients with knee osteoarthritis.

Benefits of technology

This special food can improve the expression of SPOCK2 in the blood, prevent and treat knee osteoarthritis, improve patients' quality of life, and has the advantages of being easy to industrialized production, environmentally friendly and non-toxic side effects.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119014512A_ABST
    Figure CN119014512A_ABST
Patent Text Reader

Abstract

The invention discloses a special cereal-sourced special dietary food for patients with knee osteoarthritis, which is characterized in that the formula comprises the following raw material components in parts by weight: 5g of millet, 5g of pearl barley, 5g of buckwheat, 5g of quinoa, 5g of oat and 5g of sorghum, totally 30g. According to the special physiological status and nutritional requirements of the KOA patient, the special composite dietary food for the KOA patient is provided, and the cereal source components of the special composite dietary food can protect the bone joints of the patient.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of nutritional health food, and in particular to a cereal-based special dietary food specially used for patients with knee osteoarthritis. Background Art

[0002] Knee osteoarthritis (KOA) is a chronic degenerative joint disease in osteoarthritis, which often causes joint pain, stiffness and dysfunction. KOA significantly affects the quality of life of patients, with a global prevalence of 4711.84 / 100,000. The main characteristics of KOA are the destruction of articular cartilage and other pathological changes throughout the joint. In cartilage tissue, chondrocytes receive nutrients through the diffusion of synovial fluid, which is the exudate of blood around joint tissue. In recent years, more and more studies have used components in plasma to treat KOA, such as platelet-rich plasma. However, it is not clear whether the molecules contained in plasma act on KOA. Food intake management has been used to improve the function of many diseases with few adverse reactions. Therefore, under the premise of ensuring food safety, dietary intervention and nutritional regulation have become the most urgent links to improve health levels and ensure the improvement of people's livelihood, among which daily dietary intervention is the key.

[0003] Cereals are typical staple foods for Chinese residents and the main source of energy intake. Reasonable combination can prevent and treat KOA patients at a low cost and improve the quality of life of patients as an auxiliary means of medical treatment.

[0004] There is a lack of KOA-related grain-derived special dietary foods on the current market. Summary of the invention

[0005] In order to overcome the above technical defects, the purpose of the present invention is to provide a special dietary food derived from grains for patients with knee osteoarthritis. According to the special physiological state and nutritional needs of KOA patients, a special compound dietary food is provided for KOA patients, whose grain-derived ingredients can protect the patients' bones and joints.

[0006] In order to achieve the above object, the technical solution adopted by the present invention is:

[0007] A cereal-based special dietary food specially for patients with knee osteoarthritis, wherein the raw material ingredients of the formula include, by weight, 5g of millet, 5g of coix seed, 5g of buckwheat, 5g of quinoa, 5g of oats and 5g of sorghum, for a total of 30g.

[0008] Seven co-expressed small molecules were detected in all the above raw material components, namely guanosine, L-glutamic acid, methylmalonic acid, phosphate, spermine, sucrose and succinic acid, all of which had binding sites with the SPOCK2 protein.

[0009] The preparation method is as follows: weigh the raw material components according to the above formula, clean them, crush and mix them in a dry grinder at room temperature to obtain grain powder, then bake the prepared grain powder in a pot at 400-600°C until cooked, sieve, add water, sugar and salt into the pot, stir-fry continuously until dry, and then crush into a grain-based special dietary food with a fineness of 100-120 mesh.

[0010] The cereal-derived special dietary food of the present invention has the advantages of being easy to prepare, easy to carry, rich in nutrition and having no toxic or side effects.

[0011] The application of the cereal-derived special dietary food was used to establish anterior cruciate ligament transection model in rats. After 24 hours, the rats were randomly divided into a negative control group and 7 experimental groups with different ingredient ratios, with 10 rats in each group.

[0012] The special dietary food was prepared into an aqueous solution and fed to rats by gavage (2 ml / rat). The negative control group was given normal drinking water for 30 consecutive days. The rats were killed on the day after the last feeding.

[0013] Mouse serum was collected and the expression of Spock2 was detected by ELISA to determine the optimal ratio.

[0014] Beneficial effects of the present invention.

[0015] (1) The raw materials of the present invention are cereal crops commonly sold in the domestic market, which have a wide source of raw materials, are not restricted by production areas and seasons, and are easy to industrialize;

[0016] (2) The present invention adopts a clean production process and is basically pollution-free to the environment;

[0017] (3) The use of the technology of the present invention can realize continuous production, with simple process and easy automatic control;

[0018] (4) The product of the present invention has the functions of preventing and curing diseases and maintaining human health, has a wide range of effects, has no side effects, is suitable for the peri-treatment period of KOA patients, has broad market prospects, and has significant economic and social benefits.

[0019] The optimal concentration determined in the present invention is 1:1:1:1:1:1, and this ratio can standardize the quality of the finished product and improve the quantification efficiency. In the present invention, a proper amount of sugar or salt is added according to a reasonable ratio, the sugar content is fresh and sweet, which effectively controls the sugar intake of the user, and the salt content is rich and fragrant, which effectively improves the aroma of the food. The grain-derived special dietary food of the present invention has the advantages of easy brewing, easy carrying, rich nutrition, and no toxic side effects. BRIEF DESCRIPTION OF THE DRAWINGS

[0020] Figure 1 This is a schematic diagram showing the negative correlation between knee osteoarthritis and SPOCK2 expression in the blood.

[0021] Figure 2 Schematic diagram of the seven core small molecules of six grains.

[0022] Figure 3 Schematic diagram of the interaction sites of SPOCK2 and six cereals.

[0023] Figure 4 Schematic diagram of the expression differences of blood SPOCK2 in different proportions of six kinds of grains. DETAILED DESCRIPTION

[0024] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0025] A method for preparing a special cereal-based dietary food for patients with knee osteoarthritis comprises the following steps:

[0026] (1) The theoretical basis for the effects of six cereals on KOA was clarified. First, a Mendelian randomization study confirmed that the expression of SPOCK2 was negatively correlated with KOA ( Figure 1 ), and then metabolomics was used to analyze the core seven small molecules of six cereals ( Figure 2 ), and finally the binding sites of six cereals and SPOCK2 were determined by molecular docking technology ( Figure 3 ). In short, a Mendelian randomization study was conducted on the exposure variable food intake and the outcome variable KOA in the genome-wide association study dataset, and the results showed that cereals were negatively correlated with KOA, and the core protein of their action was SPOCK2. Seven co-expressed small molecules, namely guanosine, L-glutamate, methylmalonic acid, phosphoric acid, spermine, sucrose, and succinic acid, were detected in all six cereals, all of which had binding sites with the SPOCK2 protein.

[0027] (2) Millet, coix seed, buckwheat, quinoa, oats and sorghum are mixed in different proportions and then crushed and mixed in a dry grinder at room temperature to obtain grain flour, and then the prepared grain flour is baked in a pot at 400-600°C until cooked.

[0028] (3) The prepared grain powder is baked in a pot at 400-600°C until cooked, sifted, and then water, sugar, and salt are added into the pot, and the mixture is continuously stir-fried until dry, and then crushed into a grain-derived special dietary food with a fineness of 100-120 mesh.

[0029] Secondly, the present invention also provides a cereal-based nutritional special dietary food prepared by the above method with an optimal ratio of 1:1:1:1:1:1 ( Figure 4 ).

[0030] Determination of SPOCK2 expression content: Referring to the ELISA method, use a pyrogen-free, endotoxin-free collection tube or centrifuge tube to collect rat blood samples, place at room temperature for 2 hours or at 4°C overnight to precipitate the serum. Centrifuge at 4°C 2500-3500×g for 20 minutes, and carefully collect the supernatant. Draw a standard curve with the standard product, and set up blank wells and test sample wells respectively. First add 40μL of the sample to the test sample well on the enzyme-labeled plate, and then add 10μL of biotin-labeled anti-SPOCK2 antibody. Add the sample to the bottom of the well of the enzyme-labeled plate, try not to touch the well wall, and gently shake to mix. Add 50μL of enzyme-labeled reagent to each well, except for the blank well. Seal the plate with a sealing film and incubate at 37°C for 30 minutes. Carefully peel off the sealing film, discard the liquid, spin dry, fill each well with washing solution, let it stand for 30 seconds and discard it, repeat this 5 times, and pat dry. First add 50μL of color developer A to each well, then add 50μL of color developer B, gently shake and mix, and color at 37℃ in the dark for 10 minutes. Add 50μL of stop solution to each well to stop the reaction (the blue color turns yellow immediately). Zero the blank well and measure the absorbance (OD value) of each well in sequence at 450nm. The measurement should be performed within 15 minutes after adding the stop solution. The group with the highest SPOCK2 expression is the group with the best grain ratio.

[0031] The present invention is further described below in conjunction with examples, but the embodiments of the present invention are not limited thereto.

[0032] Embodiment 1,

[0033] The study on the correlation between KOA patients and the expression of SPOCK2 in the blood involved in this example ( Figure 1 ), through Mendelian randomization research technology, it was determined that KOA patients were negatively correlated with the expression of SPOCK2 in the blood. Metabolomics analysis of the core seven small molecules of six cereals ( Figure 2 ), and the interaction sites of SPOCK2 and six cereals were determined by molecular docking technology ( Figure 3 ). In short, a Mendelian randomization study was conducted on the exposure variable food intake and the outcome variable KOA in the genome-wide association study dataset, and the results showed that cereals were negatively correlated with KOA, and the core protein of their action was SPOCK2. Seven co-expressed small molecules, namely guanosine, L-glutamate, methylmalonic acid, phosphoric acid, spermine, sucrose, and succinic acid, were detected in all six cereals, all of which had binding sites with the SPOCK2 protein.

[0034] Embodiment 2,

[0035] The compound special dietary food for KOA patients involved in this embodiment is composed of the following raw materials in the following mass ratios:

[0036] Based on the theoretical basis of Example 2, millet, coix seed, buckwheat, quinoa, oats and sorghum are taken in different proportions (Table 1), cleaned, crushed and mixed in a dry grinder at room temperature to obtain cereal powder, and then the prepared cereal powder is baked in a pot at 400-600°C until cooked. After sieving, water, sugar and salt are added into the pot and mixed, stir-fried until dry, and then crushed into a cereal-derived special dietary food with a fineness of 100-120 mesh. The composite special dietary food of the present invention is obtained by microwave sterilization at 25-45°C for 2-3 hours.

[0037] Embodiment 3,

[0038] A rat experiment was conducted using the composite special dietary food for patients with knee osteoarthritis of Example 2 ( Figure 4 )

[0039] Knee osteoarthritis model: Anterior cruciate ligament transection model was established in rats. After 24 hours, the rats were randomly divided into a negative control group and 7 experimental groups with different component ratios (Table 1), with 10 rats in each group. The special dietary food in Example 1 was prepared into an aqueous solution and the rats were gavaged (2 ml / rat). The negative control group was given normal drinking water for 30 consecutive days. The rats were killed the day after the last feeding. The mouse serum was taken and the expression of Spock2 was detected by ELISA to determine the optimal ratio.

[0040] The experimental results show that the composite special dietary food for patients with knee osteoarthritis is prepared with six kinds of cereals as main raw materials according to the nutritional needs of patients with knee osteoarthritis, and the optimal ratio is finally determined to be 1:1:1:1:1:1. The present invention has no drug side effects and can increase the expression of Spock2 in the blood, so it can prevent and treat knee osteoarthritis, and can comprehensively improve the quality of life of patients with knee osteoarthritis.

[0041] Table 1. Different proportions of six cereals in different groups (30g in total)

[0042]

[0043] Although the present invention has been disclosed as above in the form of a preferred embodiment, it is not intended to limit the present invention. Anyone familiar with this technology can make various changes and modifications without departing from the spirit and scope of the present invention. Therefore, the scope of protection of the present invention should be based on the definition of the claims.

Claims

1. A cereal-based special dietary food for patients with knee osteoarthritis, characterized in that: The raw material components of the formula include, by weight: 5g millet, 5g coix seed, 5g buckwheat, 5g quinoa, 5g oats and 5g sorghum, totaling 30g.

2. The cereal-based special dietary food for patients with knee osteoarthritis according to claim 1, characterized in that: Seven co-expressed small molecules were detected in all the above raw material components, namely guanosine, L-glutamic acid, methylmalonic acid, phosphate, spermine, sucrose and succinic acid, all of which had binding sites with the SPOCK2 protein.

3. The method for preparing a special cereal-based dietary food for patients with knee osteoarthritis according to claim 1 or 2, characterized in that: Weigh the raw material components according to the above formula, clean them, crush and mix them in a dry grinder at room temperature to obtain grain powder, then bake the prepared grain powder in a pot at 400-600℃ until cooked, sieve, add water, sugar and salt into the pot, stir-fry until dry, and then grind it into a grain-based special dietary food with a fineness of 100-120 mesh.

4. The use of a cereal-based special dietary food for patients with knee osteoarthritis according to claim 1 or 2, characterized in that: The rat anterior cruciate ligament transection model was established, and 24 hours later, the rats were randomly divided into a negative control group and seven experimental groups with different component ratios, with 10 rats in each group; The special dietary food was prepared into an aqueous solution and fed to rats by gavage (2 ml / rat). The negative control group was given normal drinking water for 30 consecutive days. The rats were killed on the day after the last feeding. Mouse serum was collected and the expression of Spock2 was detected by ELISA to determine the optimal ratio.